Industry Snapshot - Contrast Agent Market in China 2021

October 2021 | 65 pages | ID: I649F881C7A8EN
Gen Consulting Company

Abstracts

A contrast agent (or contrast medium) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. In 2020, the contrast agent market in China stood at USD 2,313 million. Recording a CAGR of 11.7% from 2021 to 2027, the worth is projected to reach ~USD 5,017 million by 2027, according to a new report by Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into contrast agent market in China. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments.

The contrast agent market is segmented on the basis of modality, and product. The contrast agent market is segmented as below:

By modality:

• MRI
• X-ray/CT
• ultrasound

By product:

• iodixanol
• iohexol
• iopamidol
• iopromide
• ioversol
• diatrizoate

The report also provides a detailed analysis of several leading contrast agent market vendors that include Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., General Electric Company, Jiangsu Hengrui Medicine Co., Ltd., Liebel-Flarsheim Company LLC, Shanghai Bolai Kexinyi Pharmaceutical Industry Co., Ltd., Yangtze River Pharmaceutical Group Co. Ltd., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2017 to 2027 considering 2020 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the contrast agent market in China.
• To classify and forecast the contrast agent market in China based on modality, and product.
• To identify and analyze the profile of leading players operating in the contrast agent market in China.

Why Choose This Report

• Gain a reliable outlook of the contrast agent market in China forecasts from 2021 to 2027 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

1.1 Market definition
1.2 Key benefits
1.3 Market segment

PART 2. METHODOLOGY

2.1 Primary
2.2 Secondary

PART 3. EXECUTIVE SUMMARY

PART 4. CONTRAST AGENT MARKET IN CHINA, BY MODALITY

4.1 MRI
  4.1.1 Market size and forecast
4.2 X-ray/CT
  4.2.1 Market size and forecast
4.3 Ultrasound
  4.3.1 Market size and forecast

PART 5. CONTRAST AGENT MARKET IN CHINA, BY PRODUCT

5.1 Iodixanol
  5.1.1 Market size and forecast
5.2 Iohexol
  5.2.1 Market size and forecast
5.3 Iopamidol
  5.3.1 Market size and forecast
5.4 Iopromide
  5.4.1 Market size and forecast
5.5 Ioversol
  5.5.1 Market size and forecast
5.6 Diatrizoate
  5.6.1 Market size and forecast

PART 6. MARKET SHARE ANALYSIS

6.1 Bayer AG
6.2 Beijing Beilu Pharmaceutical Co., Ltd.
6.3 General Electric Company
6.4 Jiangsu Hengrui Medicine Co., Ltd.
6.5 Liebel-Flarsheim Company LLC
6.6 Shanghai Bolai Kexinyi Pharmaceutical Industry Co., Ltd.
6.7 Yangtze River Pharmaceutical Group Co. Ltd.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER
ABOUT GEN CONSULTING COMPANY